[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352300-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352300-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","circrnas-in-immuno-metabolic-reprogramming-of-chordoma-cancer-molecular-crosstalk-and-therapeutic-potential","CircRNAs in Immuno-Metabolic Reprogramming of Chordoma Cancer - Molecular Crosstalk and Therapeutic Potential","","Chordoma is a rare, slow-growing, locally invasive malignant bone tumor with notable recurrence, metastatic potential, and resistance to standard therapies. Altered cancer energy metabolism drives unchecked growth and survival, while non-coding RNAs—especially circular RNAs (circRNAs)—emerge as key regulators linking metabolism and immune control. This review explains how circRNAs modulate glycolytic enzymes and immunometabolic signaling, including immune checkpoint signaling and macrophage polarization. It also outlines pathway regulation such as PI3K/AKT/mTOR and NRF2, plus mechanisms like miRNA sponging. The therapeutic translational potential of circRNA-targeted strategies is highlighted, supporting precision treatment development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/circrnas-in-immuno-metabolic-reprogramming-of-chordoma-cancer-molecular-crosstalk-and-therapeutic-potential/352300/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/circrnas-in-immuno-metabolic-reprogramming-of-chordoma-cancer-molecular-crosstalk-and-therapeutic-potential/352300.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is chordoma considered difficult to treat?","Question",{"text":63,"@type":64},"Chordoma has high recurrence rates, possible metastasis, and local aggressiveness, along with resistance to several standard treatment techniques.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do circRNAs connect cancer metabolism and immune function?",{"text":68,"@type":64},"CircRNAs influence metabolic reprogramming in tumor cells and modulate immune cell functions, including immunological checkpoint signaling and macrophage polarization.",{"name":70,"@type":61,"acceptedAnswer":71},"Which signaling pathways are emphasized in circRNA-mediated immunometabolism?",{"text":72,"@type":64},"The review highlights regulation involving PI3K/AKT/mTOR and NRF2, and describes processes such as miRNA sponging that shape an immunosuppressive, metabolically supportive tumor microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352300,1790151709,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nCircRNAs in Immuno-Metabolic Reprogramming of Chordoma Cancer: Molecular Crosstalk and Therapeutic Potential  \nNegar Taghavi Pourianazar   \nMedical Laboratory Techniques, Istanbul Aydin University, 34295 Istanbul, Turkey; negartaghavi22@gmail.com or[negarpourianazar@aydin.edu.tr](negarpourianazar@aydin.edu.tr)  \nAbstract  \nSlow-growing and locally invasive, chordoma is a rare malignant bone tumor, with a reported annual worldwide incidence of 0.08 per 100,000 cases. It accounts for about  \n3 percent of all bone tumors and about 20 percent of primary spinal tumors. The incidence rates vary between countries and races, with white/Caucasian males in the 5th or 6th decade of life having a higher prevalence. Chordoma poses significant challenges because of its high recurrence rate and resistance to several standard treatment techniques. All cancers, including chordomas, have altered energy metabolism processes that contribute to their unchecked growth and survival. The significance of non-coding RNAs, particularly circular RNAs (circRNAs), as key regulators at the intersection of cellular metabolism and immune function has been highlighted by recent discoveries. By focusing on important glycolytic enzymes in tumor cells and altering metabolic reprogramming pathways, CircRNAs can influence cancer metabolic adaptability. Furthermore, via influencing immune cell functions as immunological checkpoint signaling and macrophage polarization, circRNAs influence immune evasion in the tumor microenvironment. These frequently happen via regulating important pathway signals, like PI3K/AKT/mTOR and NRF2, or by processes like miRNA sponging, creating a tumor microenvironment that is immunosuppressive and metabolically friendly. The translational pathway of circRNA-targeted therapeuticsis promoted as a developing pharmacological entity in this review, which also highlights recent information on the control of circRNA-mediated immunometabolism in chordoma and examines numerous important molecular axes. There are promising opportunities to develop novel precision treatments for chordoma by considering circRNAs as dual regulators of immunological and metabolic networks.  \nKeywords: immunometabolism; chordoma; circRNAs; metabolic reprogramming; immune evasion  \nAcademic Editor: Giacomina Brunetti  \nReceived: 13 December 2025  \nRevised: 2 January 2026  \nAccepted: 6 January 2026  \nPublished: 19 January 2026  \nCopyright: © 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1. Introduction  \n1.1. Chordoma: Characteristics and Pathophysiology  \nChordoma is an uncommon malignant bone tumor that grows slowly and spreads locally. It starts from the remains of the basic notochord [1] . The sacrum/coccyx and the base of the skull are the most often affected areas, and it mostly affects the axial skeleton. Despite being regarded as low-grade tumors, chordomas have a dismal prognosis because of their high recurrence rates, potential for metastasis, and local aggressiveness [2] . The molecular foundations of chordoma have been further clarified by recent research, which has also highlighted the disease’s distinct cellular features and treatment difficulties. Since these embryonic remains are normally regulated for apoptosis, the notochordal origin of  \nchordoma is crucial because they have the potential to change malignantly and cause tumor initiation [3] . This metamorphosis is frequently associated with particular genetic and epigenetic changes that promote unchecked growth and survival. Due to chordoma’s slow growth rate, diagnosis is frequently delayed, allowing the tumor to develop to a large and invasive size before being discovered. Since total surgical excision is frequently difficult, particularly in crucial anatomical regions like the base of the skull, this local invasiveness plays a significant role in i","cbCaifqAKhD8BU9C","https://ap.wps.com/l/cbCaifqAKhD8BU9C","pdf",1803013,"English","# Introduction\n## Chordoma: Characteristics and Pathophysiology\n## Pathophysiology","[{\"question\":\"Why is chordoma considered difficult to treat?\",\"answer\":\"Chordoma has high recurrence rates, possible metastasis, and local aggressiveness, along with resistance to several standard treatment techniques.\"},{\"question\":\"How do circRNAs connect cancer metabolism and immune function?\",\"answer\":\"CircRNAs influence metabolic reprogramming in tumor cells and modulate immune cell functions, including immunological checkpoint signaling and macrophage polarization.\"},{\"question\":\"Which signaling pathways are emphasized in circRNA-mediated immunometabolism?\",\"answer\":\"The review highlights regulation involving PI3K/AKT/mTOR and NRF2, and describes processes such as miRNA sponging that shape an immunosuppressive, metabolically supportive tumor microenvironment.\"}]","CircRNAs in Immuno-Metabolic Reprogramming of Chordoma Cancer - Molecular Crosstalk and Therapeutic Potential | PDF",1790098811,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60a9bad2ea025190792233a2d1d450c1.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e675adb6b5574fedb1a8635936e011db.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd80616b866d2cb60104af9111a30a5a.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3c1f506e5133db1e68d9a3512e1e24e.webp",980,1385]